✦ LIBER ✦

Phase II study of irinotecan and carboplatin in patients with the refractory or relapsed small cell lung cancer

✍ Scribed by Hirose, Takashi; Horichi, Naoya; Ohmori, Tohru; Ogura, Keiichi; Hosaka, Takamichi; Ando, Kohichi; Ishida, Hiroo; Noguchi, Hisashi; Adachi, Mitsuru

Book ID: 118571092
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 182 KB
Volume: 40
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)00075-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of weekly irinotecan and

Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer

✍ Naka, Nobuyuki; Kawahara, Masaaki; Okishio, Kyoichi; Hosoe, Shigeto; Ogawara, Mi 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Phase II Trial of Gemcitabine/Irinotecan

Phase II Trial of Gemcitabine/Irinotecan in Refractory or Relapsed Small-Cell Lung Cancer

✍ Wolfgang Schuette; Sylke Nagel; Stefan Juergens; Ines Bork; Bettina Wollschlaege 📂 Article 📅 2005 🏛 CIG Media Group, LP. 🌐 English ⚖ 508 KB

Phase II trial of amrubicin and carbopla

Phase II trial of amrubicin and carboplatin in patients with sensitive or refractory relapsed small-cell lung cancer

✍ Hirose, Takashi; Nakashima, Masanao; Shirai, Takao; Kusumoto, Sojiro; Sugiyama, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 227 KB

A phase II study of sunitinib in patient

A phase II study of sunitinib in patients with relapsed or refractory small cell lung cancer

✍ Han, Ji-Youn; Kim, Hyae Young; Lim, Kun Young; Han, Jong Hee; Lee, You Jin; Kwak 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 293 KB

Phase II study of biweekly administratio

Phase II study of biweekly administration of docetaxel and irinotecan in patients with refractory or relapsed advanced non-small cell lung cancer

✍ Takashi Hirose; Takao Shirai; Hiroo Ishida; Kohichi Ando; Tomohide Sugiyama; Soj 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 312 KB

Pilot phase II study of weekly chemother

Pilot phase II study of weekly chemotherapy with paclitaxel and carboplatin for refractory or relapsed small-cell lung cancer

✍ Kiyoshi Mori; Yukari Kamiyama; Tetsuro Kondo; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 192 KB